公开(公告)号：US20080044063A1

公开(公告)日：2008-02-21

申请号：US11798500

申请日：2007-05-14

申请人： Marc Friedman ,  Pablo Casaverde ,  Don Yansen ,  Tim McNerney ,  Yasunari Tosa ,  David Usher ,  Nicholas Accomando ,  David Muller ,  Greg Heacock ,  John Marshall

发明人： Marc Friedman ,  Pablo Casaverde ,  Don Yansen ,  Tim McNerney ,  Yasunari Tosa ,  David Usher ,  Nicholas Accomando ,  David Muller ,  Greg Heacock ,  John Marshall

IPC分类号： G06K9/62 ,  A61B3/14 ,  A61B3/15

CPC分类号： H04N7/18 ,  A61B3/1216 ,  A61B3/14 ,  G06K9/00597

摘要： A multimodal biometric identification system captures and processes images of both the iris and the retina for biometric identification. Another multimodal ocular system captures and processes images of the iris and/or the from both eyes of a subject. Biometrics based on data provided by these systems are more accurate and robust than using biometrics that include data from only the iris or only the retina from a single eye. An exemplary embodiment emits photons to the iris and the retina of both eyes, an iris image sensor that captures an image of the iris when the iris reflects the emitted light, a retina image sensor that captures an image of the retina when the retina reflects the emitted light, and a controller that controls the iris and the retina illumination sources, where the captured image of the iris and the captured image of the retina contain biometric data.

摘要翻译： 多模式生物识别系统捕获并处理虹膜和视网膜的图像以进行生物识别。 另一个多模态眼系统捕获并处理虹膜和/或从受试者的双眼的图像。 基于这些系统提供的数据的生物识别技术比使用仅包括虹膜的数据或仅来自单个眼睛的视网膜的生物识别技术更准确和鲁棒。 示例性实施例将光子发射到虹膜和双眼视网膜，虹膜图像传感器，当虹膜反射发射的光时捕获虹膜的图像;视网膜图像传感器，其在视网膜反射时捕获视网膜的图像 以及控制虹膜和视网膜照明源的控制器，其中虹膜的捕获图像和视网膜的捕获图像包含生物特征数据。

公开(公告)号：US07329501B2

公开(公告)日：2008-02-12

申请号：US11439587

申请日：2006-05-23

申请人： George Jackowski ,  John Marshall

发明人： George Jackowski ,  John Marshall

IPC分类号： G01N33/53

CPC分类号： C07K14/8114 ,  Y10T436/24

摘要： The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer, predict disease risk assessment, and develop therapeutic avenues against said disease.

摘要翻译： 本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合，以使特定样品中可验证的生物聚合物的多样性最大化。 然后，在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征所述至少一种疾病状态的存在或不存在的能力，以相对于识别所述生物聚合物的存在和/或不存在，预测疾病风险评估以及开发针对所述疾病的治疗途径。

公开(公告)号：US20070081576A1

公开(公告)日：2007-04-12

申请号：US11633956

申请日：2006-12-04

申请人： Bhaskar Ramamurthy ,  John Marshall ,  Jan-Ulco Kluiwstra

发明人： Bhaskar Ramamurthy ,  John Marshall ,  Jan-Ulco Kluiwstra

IPC分类号： G01K11/22

CPC分类号： A61B8/546 ,  A61B8/4483 ,  G01N29/326 ,  G01N2291/106 ,  G01S7/52006

摘要： Ultrasound transducer temperatures are measured in response to a temperature dependent property of the ultrasound transducer. The temperature is measured without addition of new electronics or hardware retrofits of the transducer. By implementing software and/or hardware on the ultrasound system rather than the transducer, the temperature is measured in order to provide a level of fault protection. The upgraded or new ultrasound system uses either old or new transducers while still providing temperature measurement. For example, the temperature of the lens or window is measured as a function of changes in attenuation or acoustic velocity. The receive beamformer already implemented on many ultrasound systems is used to measure a temperature dependent property of the lens or window. As another example, the dielectric constant or capacitance of one or more transducer elements is measured using additional hardware in the ultrasound system. The signal line and associated cable for one or more piezoelectric elements is switchably connected between hardware for measuring a capacitance and the receive beamformer for imaging. Rather than temperature, the operational state of the transducer may be diagnosed using acoustic energy response of the lens.

摘要翻译： 响应于超声换能器的温度依赖性测量超声换能器温度。 测量温度，无需增加换能器的新电子装置或硬件改装。 通过在超声系统而不是传感器上实施软件和/或硬件，测量温度以提供一定程度的故障保护。 升级或新的超声系统使用旧的或新的换能器，同时仍然提供温度测量。 例如，根据衰减或声速的变化来测量透镜或窗口的温度。 已经在许多超声系统上实现的接收波束形成器用于测量透镜或窗口的温度依赖性质。 作为另一示例，使用超声系统中的附加硬件来测量一个或多个换能器元件的介电常数或电容。 用于一个或多个压电元件的信号线和相关电缆可切换地连接在用于测量电容的硬件和用于成像的接收波束形成器之间。 而不是温度，可以使用透镜的声能响应来诊断换能器的操作状态。

公开(公告)号：US20070070810A1

公开(公告)日：2007-03-29

申请号：US11233720

申请日：2005-09-23

申请人： Brian Hurst ,  John Marshall ,  David O'Connor

发明人： Brian Hurst ,  John Marshall ,  David O'Connor

IPC分类号： G01V1/40

CPC分类号： G01V1/46

摘要： A longitudinally segmented acoustic transducer for a cement bond logging (CBL) tool having a plurality of adjoining PZT ring-like segments driven synchronously in parallel by one or more pulses and caused to vibrate in an anti-resonant mode, substantially below the resonant frequency of an individual segment when used in a transmitting application. When used in a receiving application, each of the plurality of transducer rings are caused to vibrate by acoustic signals detected by the transducer array, also in an anti-resonant mode. High speed digital signal processing enables on-depth, high quality data for all azimuths at each depth to be obtained, processed, normalized and either sent to the surface in real time for each 20 Hz firing cycle, as the CBL tool is pulled toward the surface, or stored in a memory module in digital form for later retrieval. Built-in calibration factors used for normalizing the output signals to the operating conditions of use may be accessed at any time.

摘要翻译： 一种用于水泥结合测井（CBL）工具的纵向分段的声换能器，其具有多个邻接的PZT环形段，其通过一个或多个脉冲并行驱动并且以反谐振模式振动，基本上低于谐振频率 在传送应用程序中使用的单个段。 当在接收应用中使用时，通过由换能器阵列检测的声信号也使多个换能器环中的每一个也以反谐振模式振动。 高速数字信号处理使得能够获得，处理，归一化每个深度的所有方位角的深度，高质量数据，并且在每个20Hz的点火周期内实时地发送到表面，因为CBL工具被拉向 表面或以数字形式存储在存储器模块中以供稍后检索。 可以随时访问用于将输出信号归一化到使用条件的内置校准因子。

公开(公告)号：US20070031979A1

公开(公告)日：2007-02-08

申请号：US11580470

申请日：2006-10-12

申请人： George Jackowski ,  John Marshall

发明人： George Jackowski ,  John Marshall

IPC分类号： G01N33/50 ,  G01N33/543

CPC分类号： C07K14/47 ,  Y10T436/24 ,  Y10T436/255

摘要： The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer, predict disease risk assessment, and develop therapeutic avenues against said disease.

摘要翻译： 本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合，以使特定样品中可验证的生物聚合物的多样性最大化。 然后，在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征所述至少一种疾病状态的存在或不存在的能力，以相对于识别所述生物聚合物的存在和/或不存在，预测疾病风险评估以及开发针对所述疾病的治疗途径。

公开(公告)号：US20060221974A1

公开(公告)日：2006-10-05

申请号：US11097798

申请日：2005-04-02

申请人： Stephen Hilla ,  Kenneth Potter ,  John Marshall

发明人： Stephen Hilla ,  Kenneth Potter ,  John Marshall

IPC分类号： H04L12/56

CPC分类号： H04L47/10 ,  H04L45/60 ,  H04L47/125 ,  H04L47/2441 ,  H04L47/266 ,  H04L47/30

摘要： Techniques for distributing data packets over a network link bundle include storing an output data packet in a data flow queue based on a flow identification associated with the output data packet. The flow identification indicates a set of one or more data packets, including the output data packet, which are to be sent in the same sequence as received. State data is also received. The state data indicates a physical status of a first port of multiple active egress ports that are connected to a corresponding bundle of communication links with one particular network device. A particular data flow queue is determined based at least in part on the state data. A next data packet is directed from the particular data flow queue to a second port of the active egress ports. These techniques allow a more efficient use of a network link bundle.

公开(公告)号：US20060211146A1

公开(公告)日：2006-09-21

申请号：US11439588

申请日：2006-05-23

申请人： George Jackowski ,  John Marshall

发明人： George Jackowski ,  John Marshall

IPC分类号： G01N33/543

CPC分类号： C07K14/8114 ,  Y10T436/24

摘要： The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer, predict disease risk assessment, and develop therapeutic avenues against said disease.

公开(公告)号：US20060211143A1

公开(公告)日：2006-09-21

申请号：US11439577

申请日：2006-05-23

申请人： George Jackowski ,  John Marshall

发明人： George Jackowski ,  John Marshall

IPC分类号： G01N33/543

CPC分类号： C07K14/78 ,  Y10T436/24 ,  Y10T436/255

摘要： The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer, predict disease risk assessment, and develop therapeutic avenues against said disease.

公开(公告)号：US20060211048A1

公开(公告)日：2006-09-21

申请号：US11437969

申请日：2006-05-19

申请人： George Jackowski ,  Brad Thatcher ,  John Marshall ,  Jason Yantha ,  Tammy Vrees

发明人： George Jackowski ,  Brad Thatcher ,  John Marshall ,  Jason Yantha ,  Tammy Vrees

IPC分类号： G01N33/53 ,  G01N33/00

CPC分类号： G01N33/6893 ,  Y10T436/24

摘要： The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer.

公开(公告)号：US07097989B2

公开(公告)日：2006-08-29

申请号：US09993287

申请日：2001-11-23

申请人： George Jackowski ,  John Marshall

发明人： George Jackowski ,  John Marshall

IPC分类号： G01N33/567 ,  A61K38/00

CPC分类号： G01N33/564 ,  G01N2800/042 ,  Y10T436/24 ,  Y10T436/255

摘要： The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer, predict disease risk assessment, and develop therapeutic avenues against the disease.

摘要翻译： 本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合，以使特定样品中可验证的生物聚合物的多样性最大化。 然后，在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征与识别生物聚合物的存在和/或不存在相关的至少一种疾病状态的存在或不存在的能力，预测疾病风险评估以及开发针对该疾病的治疗途径。